Resultados de la búsqueda 211-220 of 1906 for scad

  1. Hematología - Ensayos clínicos - Mayo Clinic

    REVOLUTION will be a multicenter registry enrolling approximately 2,500 patients. Additional patients limited to those with EGFR mutations may be enrolled ...

  2. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Inotuzumab ozogamicin is a monoclonal antibody, called inotuzumab, linked to a type of chemotherapy called calicheamicin. Inotuzumab attaches to cancer cells in ...

  3. Cirugía - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to compare two types of surgery for the treatment of uterovaginal prolapse to determine which surgery works best from a ...

  4. Hematología - Ensayos clínicos - Mayo Clinic

    Rochester, Minn., Scottsdale/Phoenix, Ariz. The standard treatment for locally advanced rectal cancer involves chemotherapy and radiation, known as 5FUCMT, (the ...

  5. Cirugía - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to compare two types of surgery for the treatment of uterovaginal prolapse to determine which surgery works best from a ...

  6. Hematología - Ensayos clínicos - Mayo Clinic

    REVOLUTION will be a multicenter registry enrolling approximately 2,500 patients. Additional patients limited to those with EGFR mutations may be enrolled ...

  7. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Rochester, Minn., Jacksonville, Fla. The purpose of this study is to look at the effects cancer and melanoma have on the immune cells found in lymph nodes. A ...

  8. Cirugía - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to compare two types of surgery for the treatment of uterovaginal prolapse to determine which surgery works best from a ...

  9. Cirugía - Ensayos clínicos - Mayo Clinic

    We hypothesize that in displaced 3- and 4-part proximal humerus fractures, rTSA will have better pain relief and functional outcomes than nonoperative treatment ...

  10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This phase II trial studies how well inotuzumab ozogamicin works in treating younger patients with CD22 positive B acute lymphoblastic leukemia that has ...